Early Effects of Nivolumab and Ipilimumab Combined Immunotherapy in the Treatment of Metastatic Melanoma in Poland: A Multicenter Experience.
- Resource Type
- Article
- Source
- Biomedicines; Oct2022, Vol. 10 Issue 10, pN.PAG-N.PAG, 14p
- Subject
NIVOLUMAB IPILIMUMAB IMMUNOTHERAPY MELANOMA PROGRESSION-free survival - Language
- ISSN
- 22279059